Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A study published by UHN's Canadian Concussion Centre (CCC), in partnership with the T.J. Watson IBM Research Center, has shown promise in discovering a potential measure to detect changes in brain structure and activity caused by traumatic brain injury.
The research, published this month in Communications Medicine, examines neurofilament light chain (NfL), a protein that is released into the blood (serum) when there is injury to the central nervous system (CNS) or neurodegeneration starts to occur. However, little is known about how levels of this biomarker – a measure that captures changes in a cell – relate to brain structure or activity.
"It's well known that traumatic brain injuries, such as concussions, can't be diagnosed using existing tools such as CT scans, or other imaging tools, on their own – there is nothing you can really see with the naked eye," says Dr. Carmela Tartaglia, clinician-scientist, CCC and a co-author of the study. "So we need to look at alternatives, such as these biomarkers, that could potentially indicate that a person suffered changes to their brain as a result of multiple concussions."
Using data obtained with magnetic resonance imaging (MRI) and advanced statistical methods, the research team compared brain activity and structure in healthy people with that of former athletes with a history of multiple concussions to determine whether these can predict NfL levels in the blood.
The analysis showed a difference in the relationship between novel MRI brain measures, age, serum NfL levels and behavioural changes between the former contact sports athletes and healthy control groups. Though more research is needed, these findings indicate that a complex relationship exists between these measures, and that this kind of relationship may also be useful in understanding other neurodegenerative diseases, such as Alzheimer's disease.
Additionally, the research demonstrates how important collaboration is to furthering the understanding of concussions and the brain overall.
"The paper highlights a novel measure in MRI that was really only found because of this collaboration – the CCC had the clinical data, and IBM had the machine learning (AI) expertise," Dr. Tartaglia explains.
"These kinds of partnerships are critical as they may lead to novel biomarkers of concussion and other brain diseases."